Cassava Sciences Inc

NASDAQ:SAVA   3:59:59 PM EDT
24.07
+1.79 (+8.03%)
Earnings Announcements

Cassava Sciences Q1 Loss Per Share $0.44

Published: 05/05/2022 13:20 GMT
Cassava Sciences Inc (SAVA) - Cassava Sciences Reports First Quarter Financial Results for 2022 and Updates on Phase 3 Clinical Program.
Q1 Loss per Share $0.44.
$209.7 Million Cash and Cash Equivalents at March 31, 2022.
Q1 Earnings per Share View $-0.42 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.43

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.43

More details on our Analysts Page.